About Us

Our Vision for the Future

To Save Lives with Early Detection of Lung Cancer

At VisionGate, our mission is to save lives through the early detection and prevention of cancer. Our cutting-edge technologies are designed to accurately and quickly detect early-stage lung cancer using a simple, non-intrusive test.

You’re in
Good Hands

We’re backed by a talented team of scientists, researchers, and doctors.

With over 150 years of combined experience, our team at VisionGate has considerable knowledge in the creation of cutting-edge technologies in fields including pharmaceuticals and diagnostics.

Consisting of scientists, researchers, and doctors with backgrounds in a broad range of fields, we’ve put our heads together to develop world class early stage lung cancer detection methods.

visiongate team experience

Our Breakthrough
Technology

VisionGate offers the earliest detections of lung cancer when the chance for a sure is the best. Our quick non-intrusive test is based on 3D cellular imaging and Ai.

Non-Intrusive
Testing

Sputum (phlegm) samples from a deep cough (LuCED° Lung Test) are collected over a three-day period using a take-home test kit.

Patented
Cell-CT™ Imaging

High-resolution 3D images of sputum cells measure hundreds of disease indicators.

AI-Powered
Cancer Detection

AI-classifiers are trained to identify abnormal cells. The result is highly accurate cell classification.

Our Partners

VisionGate has strong clinical engagement with leading academic and healthcare institutions such as Northwestern Medicine, Vrijie University (Netherlands), and Kaiser Permanente.